Medicus Pharma Growth Metrics (2024-2025) | MDCX

Growth Metrics Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Growth Ratios
Assets Growth (1y) (Quarter) 198.29%78.18%
Assets (QoQ) (Quarter) 0.19%110.94%-16.40%0.84%
Cash & Equivalents Growth (1y) (Quarter) 142.21%109.04%
Cash & Equivalents (QoQ) (Quarter) -4.37%142.81%-10.42%0.50%
Cash from Operations Growth (1y) (Quarter) -234.85%-96.95%-117.85%-107.08%
Cash from Operations (QoQ) (Quarter) -135.93%-11.72%-2.89%-23.48%-38.77%-23.57%2.20%
EBIT Growth (1y) (Quarter) -200.25%-69.28%100.00%-117.28%
EBIT (QoQ) (Quarter) -108.15%34.32%-53.60%-42.97%-17.36%100.00%-51,937,233.33%
EBT Growth (1y) (Quarter) -198.85%-69.28%100.00%-117.28%
EBT (QoQ) (Quarter) -108.15%34.32%-53.60%-42.31%-17.91%100.00%-51,937,233.33%
Enterprise Value Growth (1y) (Quarter) -142.21%-106.52%
Enterprise Value (QoQ) (Quarter) 4.37%-142.81%11.51%-0.51%
EPS (Basic) Growth (1y) (Quarter) -97.19%3.20%100.00%-137.11%
EPS (Basic) (QoQ) (Quarter) -105.82%44.96%-53.51%-13.38%-1.04%100.00%-108,282,118.34%
EPS (Diluted) Growth (1y) (Quarter) -97.19%3.20%100.00%-137.11%
EPS (Diluted) (QoQ) (Quarter) -105.82%44.96%-53.51%-13.38%-1.04%100.00%-108,282,118.34%
Free Cash Flow Growth (1y) (Quarter) -234.85%-96.95%-117.85%-107.08%
Free Cash Flow (QoQ) (Quarter) -135.93%-11.72%-2.89%-23.48%-38.77%-23.57%2.20%
Net Cash Flow Growth (1y) (Quarter) 84.55%-27.70%216.49%103.88%
Net Cash Flow (QoQ) (Quarter) 768.33%-139.44%63.19%84.07%3,226.63%-36.46%-98.77%
Net Income Growth (1y) (Quarter) -198.85%-69.28%100.00%-117.28%
Net Income (QoQ) (Quarter) -108.15%34.32%-53.60%-42.31%-17.91%100.00%-51,937,233.33%
Net Income towards Common Stockholders Growth (1y) (Quarter) -198.85%-69.28%100.00%-326.05%
Net Income towards Common Stockholders (QoQ) (Quarter) -108.15%35.88%-55.20%-44.28%-17.91%100.00%-100,448,813.33%
Operating Income Growth (1y) (Quarter) -200.25%-69.28%100.00%-117.28%
Operating Income (QoQ) (Quarter) -108.15%34.32%-53.60%-42.97%-17.36%100.00%-51,937,233.33%
Profit After Tax Growth (1y) (Quarter) -198.85%-70.01%-601.32%-326.04%
Profit After Tax (QoQ) (Quarter) -112.78%37.27%-55.20%-44.28%-21.04%-158.76%5.72%
Return on Assets (QoQ) (Quarter) 1.001.00-1.00
Return on Capital Employed (QoQ) (Quarter) -0.61M0.18M-1.83M
Return on Equity Growth (1y) (Quarter) -11.0042.00
Return on Equity (QoQ) (Quarter) -2.00-3.00-1.00-6.0051.00
Share-based Compensation Growth (1y) (Quarter) 212.29%-79.94%368.48%
Share-based Compensation (QoQ) (Quarter) 1,528.35%22.41%4.61%626.07%-49.61%
Shareholder's Equity Growth (1y) (Quarter) 182.04%483.52%-54.07%-118.98%-102.16%
Shareholder's Equity (QoQ) (Quarter) -150.38%1,363.24%-32.21%-34.62%-31.49%51.27%-128.01%92.58%
Total Debt (QoQ) (Quarter) 45.01%-22.65%